Some doctors and researchers say there's not enough evidence from clinical trials that a new Alzheimer's drug is effective. Roberta Brinton, PhD, Director of the Center for Innovation in Brain Science, hopes the benefits outweigh the harm. "There are many roads to Alzheimer's, there are many on-ramps to Alzheimer's but there aren't any off-ramps yet. I think it's a game starter and it's very exciting the FDA was flexible in their approval process," Brinton said.

UArizona Health Sciences research may help both premature babies and patients with Alzheimer’s disease

Saskia Popescu, an infectious disease epidemiologist and adjunct professor at the Mel and Enid Zuckerman College of Public Health, said she wants people to get vaccinated and enjoy more flexibility. But she also doesn’t want Americans to forget — especially as they’re considering traveling outside the country — that they’re in a position that much of the world envies. “Be cognizant that other places are struggling,” Popescu said.

Dr. Shad Marvasti, an associate professor and director of public health, prevention and population health curriculum at the College of Medicine – Phoenix, discusses the slowing pace of coronavirus vaccinations in the U.S. as President Biden's July 4 goal nears.

Ivo Abraham, a professor at the College of Pharmacy, is concerned that a recent drop in e-cigarette use by teens isn't a trend, but merely a pause in an increasing trend. "Unfortunately we're going to have to wait two years for the next cycle to come out and really see if this is a trend, or do we see an uptick," Abraham said.

Dr. Murtaza Akhter, a clinical assistant professor at the College of Medicine – Phoenix, discusses a lag in vaccinations in parts of the country and concerns of a repeat surge in places that saw one last summer.

Edgar Villavicencio, a research specialist at the Mel and Enid Zuckerman College of Public Health, was selected as one of 26 aspiring Latino researchers from across the nation to join the 2021 cohort of Éxito! Latino Cancer Research Leadership Training at UT Health San Antonio.

The effectiveness of vaccines against the coronavirus stands out as one of the pandemic’s few good news stories for humanity. "We saw there was a natural pathway to immunization we could take advantage of,” said Dr. Deepta Bhattacharya, an immunobiologist at the College of Medicine – Tucson.

Health experts say smaller, labor-intensive vaccine events targeting vulnerable communities will need to continue throughout the state in order to make progress. "Where we are now is we already took care of the very vaccine-welcoming part of our population — the folks who really wanted to get vaccinated by and large have probably already had an opportunity to do so. We have to work harder for every shot. That's where we are now," said Elizabeth Jacobs, a professor of epidemiology at the Mel and Enid Zuckerman College of Public Health.